Gilead’s experimental HIV treatment shows low discontinuation rates in studies
- Uncategorized
- February 26, 2026
- No Comment
- 0
The company studied the pill in HIV patients whose virus was already suppressed, including those switching from complex multi-tablet regimens or from a guideline-recommended single-tablet treatment
